0001140361-23-035207.txt : 20230719
0001140361-23-035207.hdr.sgml : 20230719
20230719162018
ACCESSION NUMBER: 0001140361-23-035207
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ahmad Qasim Iftikhar
CENTRAL INDEX KEY: 0001985801
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41008
FILM NUMBER: 231096940
MAIL ADDRESS:
STREET 1: 1209 ORANGE STREET
CITY: WILMINGTON
STATE: DE
ZIP: 19801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IO Biotech, Inc.
CENTRAL INDEX KEY: 0001865494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870909276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
BUSINESS PHONE: 4570702980
MAIL ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
4
1
form4.xml
X0508
4
2023-07-17
0001865494
IO Biotech, Inc.
IOBT
0001985801
Ahmad Qasim Iftikhar
C/O IO BIOTECH, INC.
OLE MAALOES VEJ 3
COPENHAGEN
G7
2200
DENMARK
true
Chief Medical Officer
false
Stock Option (Right to Buy)
1.86
2023-07-17
4
A
0
288153
0
A
2033-07-17
Common Stock
288153
288153
D
One-fourth of these options vest on July 17, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.
/s/ Brian Burkavage, Attorney-in-Fact for Qasim Ahmad
2023-07-19